A Big CEO Move, Big Buffett Buys, and More
https://www.fool.com/investing/2024/08/22/a-big-ceo-move-big-buffett-buys-and-more/?source=iedfolrf0000001
Aug 22, 2024 - Motley Fool analysts talk over market news including earnings updates from Home Depot, Walmart, and Brinker.
0
J&J (JNJ) Gets FDA Nod for Chemotherapy-Free Lung Cancer Therapy
https://www.zacks.com/stock/news/2325154/j-j-jnj-gets-fda-nod-for-chemotherapy-free-lung-cancer-therapy?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2325154
Aug 21, 2024 - The approval is based on late-stage study data wherein treatment with J&J's (JNJ) Rybrevant plus Lazcluze cut the risk of disease progression or death by 30% in certain NSCLC patients.
0
Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar?
https://www.zacks.com/stock/news/2324124/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar?cid=CS-ZC-FT-style_box_etf-2324124
Aug 20, 2024 - Style Box ETF report for HDV
0
3 Top Dividend ETFs That Investors can Buy and Hold for Decades
https://www.fool.com/investing/2024/08/16/3-top-dividend-etfs-that-investors-can-buy-and-hol/?source=iedfolrf0000001
Aug 16, 2024 - You won't have to worry about tracking individual dividend stocks anymore with these funds.
0
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
https://www.fool.com/investing/2024/08/03/prediction-2-stocks-that-will-be-worth-more-than-j/?source=iedfolrf0000001
Aug 03, 2024 - These two healthcare companies have far more upside potential than Johnson & Johnson.
0
GSK Blenrep Combos for Multiple Myeloma Accepted for EU Review
https://www.zacks.com/stock/news/2306184/gsk-blenrep-combos-for-multiple-myeloma-accepted-for-eu-review?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2306184
Jul 22, 2024 - GSK announces the acceptance of its regulatory filing, seeking the approval of Blenrep combinations for the treatment of relapsed or refractory multiple myeloma, for review in the EU.
0
Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/07/17/johnson-johnson-jnj-q2-2024-earnings-call-transcri/?source=iedfolrf0000001
Jul 17, 2024 - JNJ earnings call for the period ending June 30, 2024.
0
ORIC Pharmaceuticals (ORIC) Up on Collaboration With Bayer & JNJ
https://www.zacks.com/stock/news/2303774/oric-pharmaceuticals-oric-up-on-collaboration-with-bayer-jnj?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2303774
Jul 17, 2024 - ORIC Pharmaceuticals (ORIC) teams up with Bayer and Johnson & Johnson for a phase I study on ORIC-944 in patients with metastatic prostate cancer. Its shares rise on the news.
0
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
https://www.fool.com/investing/2024/07/15/want-decades-of-passive-income-3-stocks-to-buy-now/?source=iedfolrf0000001
Jul 15, 2024 - These companies stand out for their pedigrees, robust financials, and future growth prospects.
0
3 Key Earnings Reports to Watch Next Week
https://www.zacks.com/stock/news/2301247/3-key-earnings-reports-to-watch-next-week?cid=CS-ZC-FT-stocks_in_the_news-2301247
Jul 12, 2024 - With the 2024 Q2 earnings season kicking into a much higher gear next week, there are several reports investors should keep on their radars, including these three.
0